Differential ion current activation by human 5-HT1A receptors in Xenopus oocytes:: Evidence for agonist-directed trafficking of receptor signalling

被引:17
作者
Heusler, P
Pauwels, PJ
Wurch, T
Newman-Tancredi, A
Tytgat, J
Colpaert, FC
Cussac, D
机构
[1] Ctr Rech Pierre Fabre, F-81106 Castres, France
[2] Katholieke Univ Leuven, Fac Pharmaceut Sci, Toxicol Lab, B-3000 Louvain, Belgium
关键词
GPCR; 5-HT1A receptor; agonist trafficking; electrophysiology; Xenopus oocytes;
D O I
10.1016/j.neuropharm.2005.05.001
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The subject of the present study was the functional and pharmacological characterization of human 5-HT1A receptor regulation of ion channels in Xenopus oocytes. Activation of the heterologously expressed human 5-HT1A receptor induced two distinct currents in Xenopus oocytes, consisting of a smooth inward current (I-smooth) and an oscillatory calcium-activated chloride current, I-Cl(Ca). 5-HT1A receptor coupling to both ionic responses as well as to co-expressed inward rectifier potassium (GIRK) channels was pharmacologically characterized using 5-HT1A receptor agonists. The relative order of efficacy for activation of GIRK current was 5-HT approximate to F13714 approximate to L694,247 approximate to LY228,729 > flesinoxan approximate to (+/-)8-OH-DPAT. In contrast, flesinoxan and (+/-)8-OH-DPAT typically failed to activate I-Cl(Ca). The other ligands behaved as full or partial agonists, exhibiting an efficacy rank order of 5-HT approximate to L694,247 > F13714 approximate to LY228,729. The pharmacological profile of I-smooth activation was completely distinct: flesinoxan and F13714 were inactive and rather exhibited an inhibition of this current. Ismooth was activated by the other agonists with an efficacy order of L694,247 > 5-HT approximate to LY228,729 > (+/-)8-OH-DPAT. Moreover, activation of I-smooth, was not affected by application of pertussis toxin or the non-hydrolyzable GDP-analogue, guanosine-5'-O-(2-thio)-diphosphate (GDP beta S), suggesting a GTP binding protein-independent pathway. Together, these results suggest the existence of distinct and agonist-specific signalling states of this receptor. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:963 / 976
页数:14
相关论文
共 66 条
[1]   Receptor signaling and structure: insights from serotonin-1 receptors [J].
Albert, PR ;
Tiberi, M .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2001, 12 (10) :453-460
[2]   Correlation between low/high affinity ratios for 5-HT1A receptors and intrinsic activity [J].
Assié, MB ;
Cosi, C ;
Koek, W .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 386 (01) :97-103
[3]   β-Arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors [J].
Azzi, M ;
Charest, PG ;
Angers, S ;
Rousseau, G ;
Kohout, T ;
Bouvier, M ;
Piñeyro, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (20) :11406-11411
[4]   Agonist and inverse agonist actions of β-blockers at the human β2-adrenoceptor provide evidence for agonist-directed signaling [J].
Baker, JG ;
Hall, IP ;
Hill, SJ .
MOLECULAR PHARMACOLOGY, 2003, 64 (06) :1357-1369
[5]   The 5-HT1A receptor in schizophrenia:: a promising target for novel atypical neuroleptics? [J].
Bantick, RA ;
Deakin, JFW ;
Grasby, PM .
JOURNAL OF PSYCHOPHARMACOLOGY, 2001, 15 (01) :37-46
[6]   Profound, non-opioid analgesia produced by the high-efficacy 5-HT1A agonist F 13640 in the formalin model of tonic nociceptive pain [J].
Bardin, L ;
Tarayre, JP ;
Malfetes, N ;
Koek, W ;
Colpaert, FC .
PHARMACOLOGY, 2003, 67 (04) :182-194
[7]   A review of central 5-HT receptors and their function [J].
Barnes, NM ;
Sharp, T .
NEUROPHARMACOLOGY, 1999, 38 (08) :1083-1152
[8]  
Benquet P, 2002, J NEUROSCI, V22, P9679
[9]   Maitotoxin (MTX) activates a nonselective cation channel in Xenopus laevis oocytes [J].
Bielfeld-Ackermann, A ;
Range, C ;
Korbmacher, C .
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 1998, 436 (03) :329-337
[10]   Is there a role for 5-HT1A agonists in the treatment of depression? [J].
Blier, P ;
Ward, NM .
BIOLOGICAL PSYCHIATRY, 2003, 53 (03) :193-203